Praxis Precision Medicines, Inc. (PRAX)
NASDAQ: PRAX · Real-Time Price · USD
59.30
+1.29 (2.23%)
Jul 25, 2025, 3:58 PM - Market open
PRAX Stock Forecast
Stock Price Forecast
The 10 analysts that cover PRAX stock have a consensus rating of "Strong Buy" and an average price target of $101, which forecasts a 70.32% increase in the stock price over the next year. The lowest target is $28 and the highest is $170.
Price Target: $101 (+70.32%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for PRAX stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 5 | 6 | 6 | 6 |
| Buy | 3 | 3 | 3 | 3 | 4 | 3 |
| Hold | 1 | 1 | 1 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 9 | 10 | 11 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $105 | Strong Buy | Reiterates | $105 | +77.07% | Jul 18, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $97 → $115 | Buy | Maintains | $97 → $115 | +93.93% | Jul 8, 2025 |
| Needham | Needham | Strong Buy Reiterates $80 | Strong Buy | Reiterates | $80 | +34.91% | Jun 12, 2025 |
| Oppenheimer | Oppenheimer | Buy Initiates $97 | Buy | Initiates | $97 | +63.58% | Jun 2, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Initiates $80 | Strong Buy | Initiates | $80 | +34.91% | May 7, 2025 |
Financial Forecast
Revenue This Year
435.82K
from 8.55M
Decreased by -94.90%
Revenue Next Year
19.76M
from 435.82K
Increased by 4,434.72%
EPS This Year
-13.24
from -10.21
EPS Next Year
-12.37
from -13.24
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 3.2M | 162.8M | 207.6M | ||
| Avg | 435,815 | 19.8M | 61.9M | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -63.2% | 37,243.8% | 950.4% | ||
| Avg | -94.9% | 4,434.7% | 213.4% | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -11.64 | -3.89 | -4.15 | ||
| Avg | -13.24 | -12.37 | -11.37 | ||
| Low | -15.38 | -18.98 | -17.94 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.